James Whisstock and his Monash University colleagues have uncovered how the bacterium Helicobacter pylori sticks to the stomach lining, where it can cause ulcers and sometimes cancer.
The role of Helicobacter in causing gastric ulcers was originally discovered by Australian Nobel Laureates Barry Marshall and Robin Warren.
The recent work by James and his team was performed using the Australian Synchrotron and showed how the Helicobacter pylori protein SabA interacts with sugars present on the cells that line the stomach.
An axolotl’s ability to regrow limbs and repair brain and heart tissue could shed light on how humans might one day do the same, after Melbourne scientists discovered the key role played by macrophages, immune system cells, in the animal’s regenerative process.
James Godwin and his colleagues at the Australian Regenerative Medicine Institute (ARMI) have identified the critical role of macrophages in axolotl tissue regeneration, raising the hope of future treatments for human spinal cord and brain injuries, as well as heart and liver disease.
Most people remember their first kiss but Victorian scientists have discovered that your first hug is much further back than you think.
Nicolas Plachta and his team at the Australian Regenerative Medicine Institute have discovered that embryos, when only eight cells in size, develop arm-like structures that ‘hug’ the cells into shape, helping to determine an embryo’s ultimate success.
The study, which was published in the journal Nature Cell Biology, used live imaging and fluorescent markers to capture the action in mouse embryos.
A Melbourne scientist is harvesting the memory found in reprogrammed adult cells to develop cell therapy techniques that have the potential to cure a number of diseases.
Jose Polo, of Monash University, has found that induced pluripotent stem (iPS) cells don’t lose all their memory after reprogramming, flagging the possibility that a better understanding of these stem cells will aid regenerative medicine.
“Basically an iPS cell derived from muscle is more likely to reprogram back into muscle cells, while iPS cells derived from skin will generate skin cells,” says Jose. “And this could influence what type of iPS cell you might choose to generate a specific cell type.”
An accidental discovery by Melbourne researchers has revealed the purpose of ‘mystery’ immune cells in the gut, shown how our immune system interacts with the complex bacteria ecology found there, and opened new paths for drug discovery.
Our guts, lungs and mouths are lined with mysterious immune cells that make up to 10 per cent of the T cells in our immune system. These immune cells, known as mucosal-associated invariant T cells (MAITs), detect reactive intermediates in the synthesis of vitamin B2 (riboflavin) that is made by many invasive bacteria and fungi.
Dengue fever is on the march and threatening the growing populations of Asia and even northern Australia. But a ‘vaccine’ for mosquitoes could stop it in its tracks.
A team of researchers from Melbourne, Brisbane, Cairns and Brazil has found a bacterium, Wolbachia, in fruit flies, which could stop mosquitoes from spreading dengue.
Detection of dangerous water-borne pathogens will soon be much easier, thanks to advances using microfluidic systems developed at the Melbourne Centre for Nanofabrication (MCN), the Victorian node of the Australian National Fabrication Facility (ANFF).
Microfluidics deals with the control and manipulation of fluids in tiny, constrained volumes, in order to perform scientific tasks. The advantages in such systems centre around the cost and effort savings associated with miniaturisation and automation. Continue reading Small devices to fight a big disease→
Our blood has a built-in system for breaking up heart attack-inducing clots—and we’re a step closer to drugs that could switch that system on at will.
Australian researchers have won the decades-long race to define the structure of plasminogen—a protein whose active form quickly dissolves blood clots.
The current crop of clot-busting drugs have many side effects, including bleeding and thinning of the blood, so harnessing the body’s own mechanism for clearing clots could offer a better way. Continue reading Clues to switching off your blood clots→
Unhealthy cells are less “squishy” than their healthy counterparts. That difference is used by a small device developed by engineers at Monash University to test living blood cells for diseases, such as malaria and diabetes. The device can then sort the cells for future culturing and experimentation without harming them.
The patented “lab-on-a-chip” and accompanying control system has attracted considerable interest from pharmaceutical companies, according to co-inventor Dr Greg Sheard of the Department of Mechanical and Aerospace Engineering. Continue reading Health check for live cells→
An inexpensive, environmentally friendly alternative to a toxic coating currently used in Australian naval helicopters has been developed at Monash University in collaboration with CAST Cooperative Research Centre in Melbourne.
The magnesium alloy used to house the gearbox of Royal Australian Navy SeaHawk helicopters is prone to severe corrosion in marine environments, costing millions of dollars in maintenance every year. To protect the alloy from corrosion, it is covered with a chrome-based coating that is toxic to humans and the environment.